Yersinia pestis infection medical therapy: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) |
m (Bot: Removing from Primary care) |
||
| (5 intermediate revisions by 5 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
When a | When a diagnosis of plague is suspected, appropriate specimens for diagnosis should be obtained immediately and antimicrobial therapy should be started. <ref name="pmid10635759">{{cite journal| author=| title=Plague manual--epidemiology, distribution, surveillance and control. | journal=Wkly Epidemiol Rec | year= 1999 | volume= 74 | issue= 51-52 | pages= 447 | pmid=10635759 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10635759 }} </ref><ref>{{Cite book | last1 = Longo | first1 = Dan L. (Dan Louis) | title = Harrison's principles of internal medici | date = 2012 | publisher = McGraw-Hill | location = New York | isbn = 978-0-07-174889-6 | pages = }}</ref> The drug of choice is either [[Streptomycin]] or [[Gentamicin]], but [[Tetracyclines]], [[Fluoroquinolones]], and [[Chloramphenicol]] may also be effective. The treatment regimen should be adjusted depending on the patient's age, medical history, underlying health conditions, and allergies.<ref name=CDC>{{cite web | title = Plague | url = http://www.cdc.gov/plague/healthcare/clinicians.html }}</ref> Upon evidence of [[pneumonia]], patients with suspected plague should be placed in isolation and managed under respiratory droplet precautions.<ref name="pmid8789689">{{cite journal| author=Garner JS| title=Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. | journal=Infect Control Hosp Epidemiol | year= 1996 | volume= 17 | issue= 1 | pages= 53-80 | pmid=8789689 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8789689 }} </ref>. Supportive therapy includes aggressive monitoring and management for the possibility of complications such as [[septic shock]], [[multiple organ failure]], [[acute respiratory distress syndrome]], and [[disseminated intravascular coagulopathy]]. | ||
==Medical Therapy== | ==Medical Therapy== | ||
==== | ====Antibiotic regimens==== | ||
:*1. ''' Plague treatment'''<ref>http://www.who.int/csr/resources/publications/plague/whocdscsredc992b.pdf</ref> | :*1. ''' Plague treatment'''<ref>http://www.who.int/csr/resources/publications/plague/whocdscsredc992b.pdf</ref> | ||
::* Preferred regimen (1): [[Streptomycin]] 2 g/day IM q12h for at least 10 days | ::* Preferred regimen (1): [[Streptomycin]] 2 g/day IM q12h for at least 10 days | ||
| Line 46: | Line 27: | ||
::* Alternative regimen (2): [[Sulfamethoxazole-Trimethoprim]] 1.6 g/day PO bid | ::* Alternative regimen (2): [[Sulfamethoxazole-Trimethoprim]] 1.6 g/day PO bid | ||
:::* Note: Pediatric dose: [[Sulfamethoxazole-Trimethoprim]] 40 mg/kg/day PO bid | :::* Note: Pediatric dose: [[Sulfamethoxazole-Trimethoprim]] 40 mg/kg/day PO bid | ||
====Other Classes of Antibiotics==== | |||
Other cases of [[antibiotics]], such as [[penicillins]], [[cephalosporins]], and [[macrolides]] have demonstrated to be ineffective or of variable effect in the treatment of plague and should not be used for this purpose.<ref name="pmid10635759">{{cite journal| author=| title=Plague manual--epidemiology, distribution, surveillance and control. | journal=Wkly Epidemiol Rec | year= 1999 | volume= 74 | issue= 51-52 | pages= 447 | pmid=10635759 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10635759 }} </ref> | |||
==Supportive Therapy== | ==Supportive Therapy== | ||
| Line 65: | Line 49: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Infectious Disease Project]] | |||
[[Category:Needs content]] | |||
[[Category:Infectious disease]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Medicine]] | |||
Latest revision as of 00:46, 30 July 2020
|
Yersinia pestis infection Microchapters |
|
Differentiating Yersinia Pestis Infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Yersinia pestis infection medical therapy On the Web |
|
American Roentgen Ray Society Images of Yersinia pestis infection medical therapy |
|
Risk calculators and risk factors for Yersinia pestis infection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editors-In-Chief: Esther Lee, M.A.; João André Alves Silva, M.D. [2]; Alison Leibowitz [3]
Overview
When a diagnosis of plague is suspected, appropriate specimens for diagnosis should be obtained immediately and antimicrobial therapy should be started. [1][2] The drug of choice is either Streptomycin or Gentamicin, but Tetracyclines, Fluoroquinolones, and Chloramphenicol may also be effective. The treatment regimen should be adjusted depending on the patient's age, medical history, underlying health conditions, and allergies.[3] Upon evidence of pneumonia, patients with suspected plague should be placed in isolation and managed under respiratory droplet precautions.[4]. Supportive therapy includes aggressive monitoring and management for the possibility of complications such as septic shock, multiple organ failure, acute respiratory distress syndrome, and disseminated intravascular coagulopathy.
Medical Therapy
Antibiotic regimens
- 1. Plague treatment[5]
- Preferred regimen (1): Streptomycin 2 g/day IM q12h for at least 10 days
- Note: Pediatric dose: Streptomycin 30 mg/kg/day (up to 2 g/day) IM q6-12h for at least 10 days
- Preferred regimen (2): Gentamicin 3 mg/kg/day IM or IV q8h for at least 10 days
- Note: Pediatric dose: Gentamicin 6-7.5 mg/kg/day IM or IV q8h for at least 10 days - if neonates/infants use 7.5 mg/kg/day.
- Alternative regimen (1): Chloramphenicol 50 mg/kg/day IV or PO q6h for 10 days
- Alternative regimen (2): Tetracycline 2 g/day PO qid for 10 days
- Note: Pediatric dose: Tetracycline 15 mg/kg of loading dose THEN 25-50 mg/kg/day (up to 2 g/day) PO qid for 10 days
- Alternative regimen (3): Sulfadiazine 2-4 g loading dose THEN 1 g PO q4-6h
- Alternative regimen (4): Doxycycline 200 mg/day PO q12-24h
- Note (1): Fluoroquinolones have good effect against Y. pestis in both in vitro and animal studies, but no studies have been published on its use in treating human plague.
- Note (2): Other antibiotics have been shown ineffective against plague.
- 2. Plague prophylaxis[6]
- Preferred regimen: Tetracycline 1-2 g/day PO bid-qid
- Note: Pediatric dose: Tetracycline 25-50 mg/kg/day (up to 2 g/day) PO qid for 10 days
- Alternative regimen (1): Doxycycline 100-200 mg/day PO q12-24h
- Alternative regimen (2): Sulfamethoxazole-Trimethoprim 1.6 g/day PO bid
- Note: Pediatric dose: Sulfamethoxazole-Trimethoprim 40 mg/kg/day PO bid
Other Classes of Antibiotics
Other cases of antibiotics, such as penicillins, cephalosporins, and macrolides have demonstrated to be ineffective or of variable effect in the treatment of plague and should not be used for this purpose.[1]
Supportive Therapy
Clinicians must prepare for intense supportive management of plague complications, utilizing the latest developments for dealing with Gram-negative sepsis.[7] Aggressive monitoring and management should be instituted for the possibility of:[1]
- Septic shock
- Multiple organ failure
- Adult respiratory distress syndrome (ARDS)
- Disseminated intravascular coagulopathy
Treatment of Plague During Pregnancy and in Children
With prompt and proper therapy, complications of plague in pregnancy can be prevented.
The selection of antibiotics during pregnancy is confounded by the potential adverse effects of three of the most effective drugs:
- Streptomycin may be ototoxic and nephrotoxic to the fetus.
- Tetracycline has an adverse effect on the developing teeth and bones of a fetus.
- Chloramphenicol carries a low risk of "gray baby" syndrome or bone marrow suppression.
- A judiciously administered aminoglycoside is effective and safe for both the mother and fetus, and in children. Because of its intravenous and intramuscular administration and its low risk of adverse effects, gentamicin is the preferred antibiotic for treating plague during pregnancy.[8]
References
- ↑ 1.0 1.1 1.2 "Plague manual--epidemiology, distribution, surveillance and control". Wkly Epidemiol Rec. 74 (51–52): 447. 1999. PMID 10635759.
- ↑ Longo, Dan L. (Dan Louis) (2012). Harrison's principles of internal medici. New York: McGraw-Hill. ISBN 978-0-07-174889-6.
- ↑ "Plague".
- ↑ Garner JS (1996). "Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee". Infect Control Hosp Epidemiol. 17 (1): 53–80. PMID 8789689.
- ↑ http://www.who.int/csr/resources/publications/plague/whocdscsredc992b.pdf
- ↑ http://www.who.int/csr/resources/publications/plague/whocdscsredc992b.pdf
- ↑ Wheeler, Arthur P.; Bernard, Gordon R. (1999). "Treating Patients with Severe Sepsis". New England Journal of Medicine. 340 (3): 207–214. doi:10.1056/NEJM199901213400307. ISSN 0028-4793.
- ↑ Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E; et al. (2000). "Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense". JAMA. 283 (17): 2281–90. PMID 10807389.